|
WO2010021718A1
(en)
|
2008-08-19 |
2010-02-25 |
Nektar Therapeutics |
Complexes of small-interfering nucleic acids
|
|
TWI510246B
(zh)
|
2010-04-30 |
2015-12-01 |
Molecular Partners Ag |
抑制ｖｅｇｆ－ａ受體交互作用的經修飾結合性蛋白質
|
|
AU2011333666B2
(en)
|
2010-11-26 |
2017-02-02 |
Molecular Partners Ag |
Improved capping modules for designed ankyrin repeat proteins
|
|
CN113896731A
(zh)
|
2011-02-15 |
2022-01-07 |
伊缪诺金公司 |
细胞毒性苯并二氮杂䓬衍生物
|
|
EA201792652A3
(ru)
|
2011-06-21 |
2018-09-28 |
Иммуноджен, Инк. |
Новые производные майтанзиноида с пептидным линкером и их конъюгаты
|
|
EP2887965A1
(en)
|
2012-08-22 |
2015-07-01 |
ImmunoGen, Inc. |
Cytotoxic benzodiazepine derivatives
|
|
EP2738180A1
(en)
|
2012-11-30 |
2014-06-04 |
Molecular Partners AG |
Binding proteins comprising at least two binding domains against HER2.
|
|
WO2014134486A2
(en)
|
2013-02-28 |
2014-09-04 |
Immunogen, Inc. |
Conjugates comprising cell-binding agents and cytotoxic agents
|
|
US9999680B2
(en)
|
2013-02-28 |
2018-06-19 |
Immunogen, Inc. |
Conjugates comprising cell-binding agents and maytansinoids as cytotoxic agents
|
|
JP6486908B2
(ja)
|
2013-05-31 |
2019-03-20 |
モレキュラー パートナーズ アクチェンゲゼルシャフト |
肝細胞増殖因子に結合する設計アンキリン反復タンパク質
|
|
WO2014194030A2
(en)
|
2013-05-31 |
2014-12-04 |
Immunogen, Inc. |
Conjugates comprising cell-binding agents and cytotoxic agents
|
|
KR20160079854A
(ko)
|
2013-10-31 |
2016-07-06 |
프레드 헛친슨 켄서 리서치 센터 |
변형된 조혈 줄기/선조 및 비-t 효과기 세포 및 이의 용도
|
|
RS61223B1
(sr)
|
2013-12-20 |
2021-01-29 |
Hutchinson Fred Cancer Res |
Označeni himerni efektorski molekuli i njihovi receptori
|
|
US10665324B2
(en)
|
2014-07-07 |
2020-05-26 |
Yeda Research And Development Co. Ltd. |
Method of computational protein design
|
|
PL3189056T3
(pl)
|
2014-09-03 |
2020-11-02 |
Immunogen, Inc. |
Cytotoksyczne pochodne benzodiazepinowe
|
|
US9381256B2
(en)
|
2014-09-03 |
2016-07-05 |
Immunogen, Inc. |
Cytotoxic benzodiazepine derivatives
|
|
CA2978186A1
(en)
|
2015-03-05 |
2016-09-09 |
Fred Hutchinson Cancer Research Center |
Immunomodulatory fusion proteins and uses thereof
|
|
AU2016240220B2
(en)
|
2015-04-02 |
2019-11-21 |
Molecular Partners Ag |
Designed ankyrin repeat domains with binding specificity for serum albumin
|
|
US11827904B2
(en)
|
2015-04-29 |
2023-11-28 |
Fred Hutchinson Cancer Center |
Modified stem cells and uses thereof
|
|
JP6985934B2
(ja)
|
2015-04-29 |
2021-12-22 |
フレッド ハッチンソン キャンサー リサーチ センター |
操作された造血幹細胞／前駆細胞及び非ｔエフェクター細胞、ならびにその使用
|
|
WO2017106728A2
(en)
*
|
2015-12-16 |
2017-06-22 |
University Of Washington |
Repeat protein architectures
|
|
CR20180503A
(es)
|
2016-04-14 |
2018-12-21 |
Hutchinson Fred Cancer Res |
Composiciones y métodos para programar células terapéuticas utilizando nanoportadores de ácidos nucleicos dirigidos
|
|
AR109680A1
(es)
|
2016-09-22 |
2019-01-09 |
Molecular Partners Ag |
Proteínas recombinantes y sus usos
|
|
CN117357638A
(zh)
|
2017-02-17 |
2024-01-09 |
弗雷德哈钦森癌症中心 |
用于治疗bcma相关癌症和自身免疫性失调的联合疗法
|
|
EP3589328A1
(en)
|
2017-02-28 |
2020-01-08 |
Immunogen, Inc. |
Maytansinoid derivatives with self-immolative peptide linkers and conjugates thereof
|
|
US11127483B2
(en)
|
2017-03-07 |
2021-09-21 |
Igc Bio, Inc. |
Computational pipeline for antibody modeling and design
|
|
JP2020511136A
(ja)
|
2017-03-17 |
2020-04-16 |
フレッド ハッチンソン キャンサー リサーチ センター |
免疫調節性融合タンパク質およびその使用
|
|
TW201839001A
(zh)
|
2017-04-20 |
2018-11-01 |
美商伊繆諾金公司 |
細胞毒性苯并二氮平衍生物及其綴合物
|
|
US11793885B2
(en)
|
2017-12-28 |
2023-10-24 |
Immunogen, Inc. |
Substituted benzo[5,6][1,4]diazepino[1,2-a]indoles for the treatment of proliferative disorders
|
|
EP4268831A3
(en)
|
2018-09-12 |
2024-05-22 |
Fred Hutchinson Cancer Center |
Reducing cd33 expression to selectively protect therapeutic cells
|
|
CN113631194A
(zh)
|
2019-03-21 |
2021-11-09 |
伊缪诺金公司 |
制备细胞结合剂-药物缀合物的方法
|
|
KR20220010481A
(ko)
|
2019-03-29 |
2022-01-25 |
이뮤노젠 아이엔씨 |
비정상 세포 성장의 억제 또는 증식성 질환의 치료를 위한 세포독성 비스-벤조디아제핀 유도체 및 세포결합제와 이의 접합체
|
|
RS64961B1
(sr)
|
2019-04-26 |
2024-01-31 |
Immunogen Inc |
Derivati kamptotecina
|
|
MX2021014601A
(es)
|
2019-06-04 |
2022-02-11 |
Molecular Partners Ag |
Proteinas recombinantes de union a fap y su uso.
|
|
KR20220016944A
(ko)
|
2019-06-04 |
2022-02-10 |
몰리큘라 파트너스 아게 |
개선된 안정성을 갖는 설계된 안키린 반복 도메인
|
|
WO2020245175A1
(en)
|
2019-06-04 |
2020-12-10 |
Molecular Partners Ag |
Recombinant 4-1bb binding proteins and their use
|
|
BR112021026832A2
(pt)
|
2019-07-02 |
2022-05-10 |
Hutchinson Fred Cancer Res |
Vetores ad35 recombinantes e aprimoramentos da terapia gênica relacionada
|
|
EP4073091A1
(en)
|
2019-12-11 |
2022-10-19 |
Molecular Partners AG |
Designed ankyrin repeat domains with altered surface residues
|
|
AU2020401363A1
(en)
|
2019-12-11 |
2022-06-16 |
Molecular Partners Ag |
Recombinant peptide-MHC complex binding proteins and their generation and use
|
|
US20230142283A1
(en)
*
|
2020-03-05 |
2023-05-11 |
University Of Washington |
Rigid helical junctions for modular repeat protein sculpting and methods of use
|
|
CN115916815A
(zh)
|
2020-05-06 |
2023-04-04 |
分子合作伙伴股份公司 |
新型锚蛋白重复结合蛋白及其用途
|
|
BR112022023049A2
(pt)
|
2020-05-14 |
2022-12-20 |
Molecular Partners Ag |
Proteínas multiespecíficas
|
|
CN115996945A
(zh)
|
2020-05-14 |
2023-04-21 |
分子合作伙伴股份公司 |
重组cd40结合蛋白及其用途
|
|
KR20230120139A
(ko)
|
2020-12-16 |
2023-08-16 |
몰리큘라 파트너스 아게 |
재조합 cd3 결합 단백질 및 이의 용도
|
|
EP4263607A1
(en)
|
2020-12-16 |
2023-10-25 |
Molecular Partners AG |
Novel slow-release prodrugs
|
|
KR20230155464A
(ko)
|
2021-03-09 |
2023-11-10 |
몰리큘라 파트너스 아게 |
신규한 DARPin-기반 다중특이성 T-세포 인게이저
|
|
WO2022190010A1
(en)
|
2021-03-09 |
2022-09-15 |
Molecular Partners Ag |
Novel darpin based cd33 engagers
|
|
AU2022232216A1
(en)
|
2021-03-09 |
2023-10-05 |
Molecular Partners Ag |
Protease cleavable prodrugs
|
|
US20240150475A1
(en)
|
2021-03-09 |
2024-05-09 |
Molecular Partners Ag |
Novel darpin based cd123 engagers
|
|
WO2023110983A1
(en)
|
2021-12-14 |
2023-06-22 |
Molecular Partners Ag |
Designed repeat domains with dual binding specificity and their use
|
|
WO2023131707A1
(en)
*
|
2022-01-07 |
2023-07-13 |
Universität Zürich |
Stabilizing n-cap sequences for armadillo repeat proteins
|
|
WO2023215725A1
(en)
|
2022-05-02 |
2023-11-09 |
Fred Hutchinson Cancer Center |
Compositions and methods for cellular immunotherapy
|
|
WO2024028278A1
(en)
|
2022-08-01 |
2024-02-08 |
Molecular Partners Ag |
Charge modified designed repeat domains and their use
|
|
WO2024179981A1
(en)
|
2023-02-27 |
2024-09-06 |
Molecular Partners Ag |
Darpins for use in reducing renal accumulation of drugs
|
|
WO2024251628A1
(en)
|
2023-06-06 |
2024-12-12 |
Molecular Partners Ag |
Recombinant cd16a binding proteins and their use
|
|
WO2024251742A1
(en)
|
2023-06-06 |
2024-12-12 |
Molecular Partners Ag |
Recombinant cd2 binding proteins and their use
|
|
WO2024251695A1
(en)
|
2023-06-06 |
2024-12-12 |
Molecular Partners Ag |
Recombinant cd47 binding proteins and their use
|
|
WO2025068607A1
(en)
*
|
2023-09-29 |
2025-04-03 |
Universität Zürich |
Modular armadillo repeat proteins
|
|
WO2025101820A1
(en)
|
2023-11-08 |
2025-05-15 |
Fred Hutchinson Cancer Center |
Compositions and methods for cellular immunotherapy
|
|
WO2025146487A1
(en)
|
2024-01-05 |
2025-07-10 |
Molecular Partners Ag |
Multispecific binding proteins
|
|
WO2025146491A1
(en)
|
2024-01-05 |
2025-07-10 |
Molecular Partners Ag |
Designed repeat domains with dual binding specificity for cd117 and cd47-binding agent
|
|
WO2025146490A1
(en)
|
2024-01-05 |
2025-07-10 |
Molecular Partners Ag |
Recombinant cd117 binding proteins and their use
|
|
WO2025163144A1
(en)
|
2024-01-31 |
2025-08-07 |
Molecular Partners Ag |
Recombinant mesothelin binding proteins and their use
|
|
WO2025163082A1
(en)
|
2024-01-31 |
2025-08-07 |
Molecular Partners Ag |
Dll3-specific binding constructs and their use in radiotherapy
|
|
WO2025181039A1
(en)
|
2024-03-01 |
2025-09-04 |
Molecular Partners Ag |
Therapeutic combinations comprising a multi-specific t cell engager
|
|
WO2025245169A1
(en)
|
2024-05-21 |
2025-11-27 |
Fred Hutchinson Cancer Center |
Immunotherapy cells equipped with a collagen-targeting payload
|